In esophageal cancers, SLIT2 is a migration suppressor for ESCC (esophageal squamous cell carcinoma) via inhibition of srGAP–Cdc42 signaling and membrane localization of p-FAK and p-Paxillin. This evidence concerns the gene PTK2 and esophageal squamous cell carcinoma.